Lombard expands EU launch of Altura AAA endograft system

Lombard Medical Technologies (NSDQ:EVAR) said today it expanded the European launch of its Altura endovascular stent graft to the Netherlands and Spain, touting 4 completed procedures with the device in the newly expanded regions. The Altura endograft system is designed as a transcatheter treatment for abdominal aortic aneurysms, and can be repositioned during deployment to allow for the utilization of the available aortic neck, the company said. “We’ve been very encouraged by our momentum since launching Altura in the UK and Germany in late February, and we’re delighted to be expanding the rollout into the Netherlands and Spain. We believe our new Altura stent graft delivers multiple advantage,” CEO Simon Hubbert said in a press release. Three procedures with the Altura stent graft system were performed at The Netherlands’ University Medical Center Groningen by Clark Zeebregts, Dr. Paul van Schaik and Dr. Ignace Tilliu, and a single procedure was performed at Spain’s Complexi Hospitalario Universitario by Dr. Nilo Mosquera. “After successfully completing three Altura procedures in one day, we found the device to be intuitive and simple to use. The removal of the cannulation step required for other systems is a nice feature that will enable us to predict consistent procedure times and ultimately reduce physician and patient X-ray exposure,” Zeebregts said in prepared remarks. “We are honored to be the first center in Spain to co...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Vascular Lombard Medical Technologies Source Type: news